THE IMED AMBULATORY INFUSION PUMP, ADMINISTRATION SETS
K953896 · Imed Corp. · FRN · Mar 20, 1996 · General Hospital
Device Facts
| Record ID | K953896 |
| Device Name | THE IMED AMBULATORY INFUSION PUMP, ADMINISTRATION SETS |
| Applicant | Imed Corp. |
| Product Code | FRN · General Hospital |
| Decision Date | Mar 20, 1996 |
| Decision | SESE |
| Submission Type | Traditional |
| Regulation | 21 CFR 880.5725 |
| Device Class | Class 2 |
| Attributes | Therapeutic |
Intended Use
The IMED Ambulatory Infusion System is intended for use in a health care facility as well as home health care setting to pump standard IV fluids, medications, blood and blood products into a patient in a controlled manner. The system is electrically powered, with back up battery power available, and uses rotary peristaltic pumping action to infuse fluids. The IMED Ambulatory Infusion System is capable of detecting air-in-line and occlusions.
Device Story
System consists of rotary peristaltic pump and dedicated cassette-based administration sets. Operates by physically pumping fluids at controlled rates (0.1-999 mL/hr) and volumes (0.1-9999 mL). Used in healthcare facilities or home settings by clinicians or patients. Features include battery status monitoring, secondary piggyback infusion, tamper-resistant keypad lockout, and occlusion/air-in-line detection. Provides visual and audio alarms to alert operators. System ensures controlled delivery of fluids/medications, benefiting patients requiring continuous or intermittent therapy.
Clinical Evidence
Bench testing only. Performance data from comparative functional testing and biocompatibility testing (per ISO 10993 and Tripartite Guidance) demonstrate equivalence to predicate devices.
Technological Characteristics
Rotary peristaltic pump; electrically powered with battery backup. Flow rate 0.1-999 mL/hr; volume 0.1-9999 mL. Materials meet ISO 10993 and Tripartite Biocompatibility Guidance for externally communicating devices (blood path, indirect, short-term). Features include air-in-line and occlusion detection, keypad lockout, and secondary infusion capability.
Indications for Use
Indicated for patients requiring controlled infusion of standard IV fluids, medications, blood, and blood products in healthcare facilities or home settings.
Regulatory Classification
Identification
An infusion pump is a device used in a health care facility to pump fluids into a patient in a controlled manner. The device may use a piston pump, a roller pump, or a peristaltic pump and may be powered electrically or mechanically. The device may also operate using a constant force to propel the fluid through a narrow tube which determines the flow rate. The device may include means to detect a fault condition, such as air in, or blockage of, the infusion line and to activate an alarm.
Predicate Devices
- CADD-PCA (Pharmacia Deltec)
- CADD-TPN (Pharmacia Deltec)
- CADD-PLUS (Pharmacia Deltec)
- Gemini PC-2TX Infusion Pump/Controller (IMED Corporation)
- Gemini series of IV Administration Sets (IMED Corporation)
Related Devices
- K251640 — SIGMA Spectrum Infusion Pump with Master Drug Library · Baxter Healthcare Corporation · Jul 28, 2025
- K954826 — DISETRONIC MULTIFUSE PUMP SYSTEM · Disetronic Medical Systems · May 24, 1996
- K980751 — SABRATEK 4040 INFUSION PUMP · Sabratek Corp. · Feb 24, 1999
- K042696 — BODYGUARD INFUSION PUMP SYSTEM · Caesarea Medical Electronics , Ltd. · Mar 11, 2005
- K110901 — SYMBIQ INFUSION AND ADMINSTRATION SET · Hospira, Inc. · Mar 5, 2012
Submission Summary (Full Text)
{0}
IMED Corporation
9775 Businesspark Avenue
San Diego, CA 92131-1699
U.S.A.
Telephone: (619) 566-9000
Telex: 249061 IMED UR
FAX: (619) 693-9434
K953896
imed
MAR 20 1996
# SAFETY AND EFFECTIVENESS SUMMARY
(Page one)
## 1.0 SUBMITTER INFORMATION
IMED Corporation
9775 Businesspark Ave.
San Diego, CA 92131-1699
Contact Person: Ahmad Sajadi, Manager, Regulatory Affairs
## 2.0 DEVICE NAME
Trade Name: The IMED Ambulatory Infusion Pump and Administration Sets
Common Names: Infusion Pump
Intravascular Administration Sets
Classification Names: Infusion Pumps (21 CFR 880.5725),
Class II
IV Administration Sets (21 CFR 880.5440),
Class II
## 3.0 PREDICATE DEVICE
The IMED Ambulatory Infusion Pump is substantially equivalent to the CADD series of ambulatory infusion pumps (CADD-PCA®, CADD-TPN™, and CADD-PLUS®). These devices are currently being marketed by Pharmacia Deltec (St. Paul, MN). Some features of the IMED Ambulatory Infusion Pump are equivalent to the Gemini PC-2TX Infusion Pump/Controller. The IMED Ambulatory Administration Sets are substantially equivalent to the Gemini series of IV Administration Sets. The Gemini devices have been reviewed by FDA and are currently being marketed by IMED Corporation (San Diego, CA).
657
{1}
IMED Corporation
9775 Businesspark Avenue San Diego, CA 92171 1699 U.S.A.
Telephone (619) 566-9000
Telex 249061 IMED UR
FAX (619) 693-9434
# imed
## SAFETY AND EFFECTIVENESS SUMMARY
(Page two)
### 4.0 DESCRIPTION OF THE SUBJECT DEVICE
The IMED Ambulatory Infusion System is comprised of a cassette assembly and the pump. The system uses a rotary peristaltic pumping action which physically pumps fluid to the patient when used in conjunction with the dedicated administration sets. Various configurations of the IV administration sets are available.
The IMED Ambulatory Infusion System incorporate the following features:
- Battery status Indicator; provides estimated remaining battery run time.
- Ease of Use; provides operator queries, visual and audio alarms.
- Flow Rates; range of 0.1-999 mL/hr
- Free Flow Protection; administration set-based protection.
- Occlusion Pressure; provides multiple detection options.
- Secondary Infusion; provides dual rate sequential piggyback infusions.
- Tamper-resistant Mode; provides the ability to lockout keypad.
- Volume-To Be-Infused; range of 0.1-9999 mL.
### 5.0 INTENDED USE OF THE SUBJECT DEVICE
The IMED Ambulatory Infusion System is intended for use in a health care facility as well as home health care setting to pump standard IV fluids, medications, blood and blood products into a patient in a controlled manner. The system is electrically powered, with back up battery power available, and uses rotary peristaltic pumping action to infuse fluids. The IMED Ambulatory Infusion System is capable of detecting air-in-line and occlusions.
### 6.0 TECHNOLOGICAL ASPECTS OF THE SUBJECT DEVICE
The technological aspects of the IMED Ambulatory Infusion Pump and Administration Sets are substantially equivalent to the technological aspects of the CADD series of infusion pumps and IMED Gemini Administration Sets. This is supported by the comparison of the design and component materials of both systems. The performance data resulting from the comparative functional testing also support the substantial equivalence claim to the predicate device. The IMED Ambulatory System complies with the applicable safety and/or performance standards.
{2}
IMED Corporation
9775 Businesspark Avenue San Diego, CA 92131-1699 USA
Telephone (619) 566-9000
Telex 249061 IMED UR
FAX (619) 693-9434
# imed
## SAFETY AND EFFECTIVENESS SUMMARY
(Page three)
## TECHNOLOGICAL ASPECTS (CONT'D)
The IMED Ambulatory Administration Sets are equivalent to the Gemini Administration Sets. The materials are equivalent in that per the device category definition in the Tripartite Biocompatibility Guidance For Medical Devices and ISO 10993; Biological Testing of Medical and Dental Materials and Devices, Part 1, Guidance on Selection of Tests (as modified by FDA effective 1 July 1995), both are "Externally Communicating Devices for Blood Path Indirect and Short-term Contact Duration." Consequently all materials must meet the same testing criteria as outlined in the above referenced documents. Biocompatibility data to support this claim is provided.
The conclusion drawn from the Performance Data demonstrates that the IMED Ambulatory Infusion Pump and Administration Sets are equivalent to legally marketed devices and that they perform as well as or better than the predicate devices.
## 7.0 CERTIFICATION
I hereby certify that to the best of my knowledge all information contained in this Premarket Notification is truthful and accurate and that no material fact has been omitted.

Ahmad Sajadi
Manager, Regulatory Affairs
Date: August 15, 1995
659